Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours.
Berlin Cures Welcomes Renowned Immunologist Professor Danny Altmann to its Advisory Board – Biotech Investments
Issuer: Berlin Cures Holding AG / Key word(s): Personnel/Research Update 29.08.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.